Abiopharma

New Form 8-K - Akari Therapeutics Plc Filed: 2025-08-29 AccNo: 0001641172-25-026032 Size: 771 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits